ERBB2 and neoplasm: Evaluating with Oncomine data, we found most target genes (BCL2, ERBB2/3, SIRT7, ETS1, Mcl-1, IL6R, and LIN28B) were significantly activated in HCC tumor tissues, consistent with miR-125b underexpression.